2018 Jun. 06
Andrew H. J. Wang Is Elected the President of IUBMB, Collaborations with Tang Prize Foundation to Further Biotechnology Research

The Tang Prize Foundation signed a nine-year memorandum with the International Union of Biochemistry and Molecular Biology (IUBMB) in 2016, sponsoring conferences in the field of biochemistry and molecular biology and financially supporting young researchers for travel expense or relocation. In the 24th IUBMB Congress, inaugural Tang Prize Foundation Biopharmaceutical Science laureate Professor Tasuku Honjo was invited to present the Tang Prize Lecture right after the Opening Ceremony. Professor Andrew H.-J. Wang, Academician of Academia Sinica, was the host of the Tang Prize Lecture. This year, the theme of the congress is “Integrating Science for Bio-Health Innovation.” More than 2,500 people, including many leading biochemistry and molecular biology scientists, attended the ceremony.

IUBMB has regional associations in four continents across the globe. The members come from 77 different countries. Dr. Jenn-Chuan Chern, CEO of the Tang Prize Foundation, said IUBMB has an indispensable role in biotechnology. The congress is held every three years, and it has an indispensable role in biotechnology. Professor Wang is an eminent biochemistry and molecular biology scientist. He will take over the President seat in this congress on June 6th. The term of the presidency is three years, and Professor Wang feels honored to be elected to this position. Professor Wang and Professor Chi-Huey Wong, former President of the Academia Sinica, helped to form the bond between IUBMB and The Tang Prize Foundation. The collaboration includes educational programs, for example, building interactive learning platform and sponsoring young scientist travel expense. These young scientists will bring in new voices and a more dynamic and vibrant research culture.

Professor Wang said IUBMB congress is a great opportunity to share the philosophy of the Tang Prize. The contributions of the scientists are recognized by the Tang Prize and the world.

Dr. Samuel Yin established the Tang Prize in 2012. The prize recognizes supports contributors for their revolutionary efforts in the four major fields of Sustainable Development, Biopharmaceutical Science, Sinology, and Rule of Law. The Tang Prize in Biopharmaceutical Science recognizes original biopharmaceutical or biomedical research that has led to significant advances towards preventing, diagnosing and/or treating major human diseases to improve human health.

2018 Tang Prize laureates will be announced at 10 AM (GMT+8) between June 18 and 21 by category in succession. The announcement will be streaming live on the official website.